A recent study conducted a longitudinal analysis of PD-L1 expression in surgical samples and recurrent biopsy in non-small cell lung cancer, revealing that PD-L1 expression exhibited dynamic changes during the course of the disease (60). This evidence concerns the gene CD274 and non-small cell lung carcinoma.